# Therapeutic efficacy of quercetin in experimental pulmonary fibrosis: A meta-analysis

**Authors:** Lanhua Cai, Long Chen, Chunmei Lin

PMC · DOI: 10.3892/etm.2025.13054 · 2025-12-22

## TL;DR

This study finds that quercetin, a natural compound, may help reduce lung scarring and inflammation in animal models of pulmonary fibrosis.

## Contribution

A meta-analysis revealing quercetin's potential therapeutic effects on fibrotic, inflammatory, and oxidative stress pathways in pulmonary fibrosis.

## Key findings

- Quercetin reduced collagen deposition and improved histopathological scores in fibrotic models.
- The compound modulated cytokine levels and reduced inflammatory cell infiltration.
- Quercetin enhanced antioxidant capacity and reduced oxidative damage markers.

## Abstract

Pulmonary fibrosis (PF) is a fatal chronic disease characterized by progressive interstitial scarring, alveolar destruction and a persistent decline in lung function. The present study evaluated the therapeutic effects of quercetin, a natural flavonoid with potent antioxidant and anti-inflammatory properties, in animal models of PF (PROSPERO registration no. INPLASY202530122). A comprehensive literature search was performed across PubMed, Web of Science, Embase, Cochrane Library and Ovid from inception to January 2025, identifying 25 eligible preclinical studies. Data were extracted and analyzed for outcomes in three main categories: Fibrotic changes, inflammatory responses and oxidative stress parameters. Random-effects meta-analysis was employed, followed by meta-regression analysis to examine study heterogeneity. The analysis indicated that quercetin administration was associated with improvements in fibrotic indicators, showing reduced collagen deposition and improved histopathological scores. Anti-inflammatory effects were observed through modulation of cytokine levels and inflammatory cell infiltration. Additionally, quercetin demonstrated effects on oxidative stress markers, showing enhanced antioxidant capacity and reduced oxidative damage. Meta-regression analysis identified a number of moderating factors, including dosage, treatment duration, animal model selection and induction method, which contributed to heterogeneity across studies. The findings suggest that quercetin may provide beneficial effects in experimental PF models through multiple pathways. However, notable heterogeneity was observed among included studies, indicating the need for cautious interpretation of results. Further investigation with standardized protocols is recommended to validate these preliminary findings.

## Linked entities

- **Chemicals:** quercetin (PubChem CID 5280343)
- **Diseases:** pulmonary fibrosis (MONDO:0002771)

## Full-text entities

- **Diseases:** PF (MESH:D011658), inflammatory (MESH:D007249), alveolar (MESH:D002282)
- **Chemicals:** flavonoid (MESH:D005419), quercetin (MESH:D011794)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12766670/full.md

---
Source: https://tomesphere.com/paper/PMC12766670